3
Total investments
0
Early stage
1
Mid stage
1
Late stage
9y
Years active
Portfolio
3 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Observer
2019
Wildflower is a technology and services company that is transforming care delivery and payment models in women’s health to radically improve outcomes. We offer a modular suite of software, support and services, meeting providers and payers where they are in their journey to value. We are also the architect of the industry’s most comprehensive bundle for value-based maternity care, with pre-built functionality for all actuarial, clinical and operational needs.
Wildflower can help you successfully address the key drivers of women’s health outcomes while building a better future for you and the families you serve. We are ushering in a new era for women’s health. This is a smarter way to care. www.wildflowerhealth.com
Board Member
2018
N-of-One is a molecular decision support company providing clinicians with the most concise, accurate and clinically meaningful interpretation of molecular test results.
We provide the highest quality clinical interpretation that dramatically shortens the time from test results to therapeutic strategy options for each case. N-of-One is not a diagnostic laboratory or a bioinformatics company. We exist only to support clinicians in making the best therapeutic decisions.
Experience · 7 entries
All (7)
Investments (3)
Board (3)
2022
Vice President of Digital Ventures
Apr 2022
On September 1, 2018 Bon Secours Health System and Mercy Health combined to become the United States’ fifth largest Catholic health care ministry and one of the nation’s 20 largest health care systems. With 48 hospitals, thousands of providers, over 1,000 points of care and over 60,000 employees Bon Secours Mercy Health serves communities across seven states and Ireland.
We are dedicated to continually improving health care quality, safety and cost effectiveness. Our hospitals, care sites and clinicians are recognized for clinical and operational excellence. By utilizing robust measurement and reporting processes, we hold ourselves accountable for enhancing care and improving outcomes for our patients, residents and clients.
2019
Board Observer
2019
Wildflower is a technology and services company that is transforming care delivery and payment models in women’s health to radically improve outcomes. We offer a modular suite of software, support and services, meeting providers and payers where they are in their journey to value. We are also the architect of the industry’s most comprehensive bundle for value-based maternity care, with pre-built functionality for all actuarial, clinical and operational needs.
Wildflower can help you successfully address the key drivers of women’s health outcomes while building a better future for you and the families you serve. We are ushering in a new era for women’s health. This is a smarter way to care. www.wildflowerhealth.com
2018
Principal
Jun 2018
Founded in 2014, Providence Ventures ("PV") is a venture capital firm focused on Digital Health, Tech-enabled Healthcare Services, and MedTech. We target venture-class returns through direct investments in innovative healthcare companies that effectively address the top pain points of the healthcare ecosystem. We partner with entrepreneurs largely as representatives of enterprise health systems, offering customer-level insight and access to decision-makers of some of the largest customers in the market. Of note, our LP is the Providence health system, among the largest health systems in the United States. We leverage our relationship with Providence to drive adoption within and beyond our LP.
Board Member
2018
N-of-One is a molecular decision support company providing clinicians with the most concise, accurate and clinically meaningful interpretation of molecular test results.
We provide the highest quality clinical interpretation that dramatically shortens the time from test results to therapeutic strategy options for each case. N-of-One is not a diagnostic laboratory or a bioinformatics company. We exist only to support clinicians in making the best therapeutic decisions.
2017
Show all 7 entries ↓
Investment activity
2017–2019 · 3 investments
Recent (last 2 years)Earlier
